24 May 2013
Keywords: gsk, launches, advair, asthma, usa, major, marketing
Article | 18 April 2001
GlaxoSmithKline has launched its new combination drug for asthma, Advair(fluticasone propionate and salmeterol inhalation powder), in the USA.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
18 April 2001
17 April 2001
23 May 2013
© 2013 thepharmaletter.com